Page last updated: 2024-08-26

alpha-hydroxyisocaproic acid and Candidiasis

alpha-hydroxyisocaproic acid has been researched along with Candidiasis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bowyer, P; Hietala, P; Järvinen, A; Moore, C; Novak-Frazer, L; Rautemaa, R; Rautemaa, V; Sakko, M; Sorsa, T; Tjäderhane, L1
Bowyer, P; Nieminen, MT; Novak-Frazer, L; Rajendran, R; Ramage, G; Rautemaa, R; Rautemaa, V; Sorsa, T1
Bowyer, P; Hernandez, M; Kuula, H; Nieminen, MT; Novak-Frazer, L; Ramage, G; Rautemaa, R; Sorsa, T; Warn, P1

Other Studies

3 other study(ies) available for alpha-hydroxyisocaproic acid and Candidiasis

ArticleYear
2-hydroxyisocaproic acid is fungicidal for Candida and Aspergillus species.
    Mycoses, 2014, Volume: 57, Issue:4

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Caproates; Humans; Microbial Sensitivity Tests; Microbial Viability

2014
A novel antifungal is active against Candida albicans biofilms and inhibits mutagenic acetaldehyde production in vitro.
    PloS one, 2014, Volume: 9, Issue:5

    Topics: Acetaldehyde; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Caproates; Cell Proliferation; In Vitro Techniques; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Mutagens; Real-Time Polymerase Chain Reaction

2014
DL-2-hydroxyisocaproic acid attenuates inflammatory responses in a murine Candida albicans biofilm model.
    Clinical and vaccine immunology : CVI, 2014, Volume: 21, Issue:9

    Topics: Animals; Anti-Inflammatory Agents; Biofilms; Candida albicans; Candidiasis; Caproates; Disease Models, Animal; Histocytochemistry; Immunosuppressive Agents; Inflammation; Male; Mice; Microscopy; Treatment Outcome

2014